Bayer's Levitra approved from EC

Bayer and GlaxoSmithKline announced on March 7 that they have received marketing authorization from the European Commission for Levitra (vardenafil HCl) for the treatment of male erectile dysfunction. The decision follows a positive opinion by the Europe Committee for Proprietary Medicinal Product (CPMP) on November 21, 2002.

The EC's decision based on the CPMP to recommend approval of Levit...